COVID-19 Impact on Integra Lifesciences Holdings Corp.’s Revenue and Operations (Medical Devices)
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Integra Lifesciences Holding Corp. (Integra),is a medical technology company which designs, develops, manufactures and markets a wide range of medical devices, headquartered in United States of America with global manufacturing and sales reach. Integra Lifesciences is a global leader in regenerative technologies, neurosurgical and extremity orthopedic solutions dedicated to limiting uncertainty for clinicians, so they can focus on providing the best patient care. Integra offers a comprehensive portfolio of high quality, leadership brands that include AmnioExcel®, Bactiseal®, Cadence®, CertasTM, Codman®, CUSA®, DuraGen®, DuraSeal® and many more. Company’s presence is seen in Wound care management, neurological devices, general surgery, orthopedic and dental devices. The report, COVID-19 Impact on Integra Lifesciences Holdings Corp.'s Revenue and Operations (Medical Devices) presents a deep dive analysis into how Integra Lifesciences Holdings Corp is placed to respond to the COVID-19 crisis, by examining its sector performance and competitiveness.
Scope
The report provides a comprehensive analysis of the impact of COVID-19 on Integra Lifesciences Holdings Corp. –
– It provides insights on Integra Lifesciences Holdings Corp.'s exposure to the regions and businesses impacted by the COVID-19 outbreak.
– It offers an overview of the company’s revenue impact by region and market for 2020 due to the COVID-19 outbreak.
Key Highlights
The spread of the disease in recent days has put a much large proportion of Integra Lifesciences Holdings Corp's at risk.
In particular the heavy impact in Europe and rapid rise of COVID-19 cases in the US mean that the general outlook for sales has significantly declined in the past week.
The company may experience a short term up tick in critical care devices, but will be impacted harshly due to presence in products related to elective procedures.
Reasons to Buy
An overview of how Integra Lifesciences Holdings Corp. will be affected by the COVID-19 pandemic.
Table of Contents
Frequently asked questions
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.